| scholarly article | Q13442814 |
| P50 | author | Pamela Ohashi | Q56891473 |
| Joseph R Arron | Q61147913 | ||
| P2093 | author name string | Y Y Kong | |
| S Y Lee | |||
| B Wong | |||
| Y Choi | |||
| D E Speiser | |||
| A Santana | |||
| P2860 | cites work | T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors | Q24678367 |
| The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
| CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins | Q28281794 | ||
| TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
| FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex | Q28283294 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 | ||
| The Fas death factor | Q29620461 | ||
| The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death | Q29620519 | ||
| T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. | Q33560835 | ||
| T cell priming versus T cell tolerance induced by synthetic peptides | Q36365135 | ||
| CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity | Q37360807 | ||
| Receptor-stimulated death pathway is opened by antigen in mature T cells | Q37428024 | ||
| Signal transduction, mitotic catastrophes, and death in T-cell development | Q40495457 | ||
| Negative selection of lymphocytes | Q40807431 | ||
| Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
| A novel domain within the 55 kd TNF receptor signals cell death | Q41528172 | ||
| A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen | Q41553101 | ||
| Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis | Q43539775 | ||
| Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen | Q43554100 | ||
| Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 | ||
| Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells | Q45151385 | ||
| Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity | Q46094710 | ||
| The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. | Q46110412 | ||
| TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation | Q48064873 | ||
| T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. | Q52061612 | ||
| Lipopolysaccharide interferes with the induction of peripheral T cell death. | Q54179786 | ||
| T cell tolerance by clonal elimination in the thymus | Q56922465 | ||
| Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytesin vivo | Q63968527 | ||
| The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice | Q71678868 | ||
| A novel RING finger protein interacts with the cytoplasmic domain of CD40 | Q24306382 | ||
| A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 | Q24306620 | ||
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain | Q24306835 | ||
| FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 | ||
| RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death | Q24307376 | ||
| Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma | Q24315735 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
| TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex | Q24329065 | ||
| Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death | Q24336389 | ||
| Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor | Q24528198 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1777-1783 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | A regulatory role for TRAF1 in antigen-induced apoptosis of T cells | |
| P478 | volume | 185 |
| Q35214741 | A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival |
| Q31531135 | A survey of expressed genes in the leukocytes of Japanese flounder, Paralichthys olivaceus, infected with Hirame rhabdovirus |
| Q35083907 | Acute tumor necrosis factor-alpha-induced liver injury in the absence of tumor necrosis factor receptor-associated factor 1 gene expression |
| Q38246108 | Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis |
| Q59800859 | CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs |
| Q24647213 | CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand |
| Q24605401 | CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival |
| Q40955336 | CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs |
| Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
| Q22253249 | Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis |
| Q42631651 | Characterization and expression analysis of TNFR-associated factor 1 (TRAF1) in grass carp Ctenopharyngodon idella |
| Q42441496 | Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation |
| Q37606217 | Differential gene expression profiling of mouse uterine luminal epithelium during periimplantation |
| Q47313676 | Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy |
| Q36376371 | Enhanced Expression of Interleukin-1α and Tumor Necrosis Factor Receptor-Associated Protein 1 in Ileal Tissues of Cattle Infected withMycobacterium aviumsubsp.paratuberculosis |
| Q57191736 | Genetic Alterations of TRAF Proteins in Human Cancers |
| Q38957340 | Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy? |
| Q73980580 | Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus |
| Q45743372 | Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene |
| Q35679587 | Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection |
| Q51155091 | Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex. |
| Q34427560 | Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders |
| Q34285220 | NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors |
| Q56967454 | Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas |
| Q42227779 | Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells |
| Q41514577 | Pathways leading to cell death in T cells |
| Q34274842 | Receptor-mediated choreography of life and death. |
| Q36371153 | Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling |
| Q79846620 | Relationship between Mycobacterium avium subspecies paratuberculosis, IL-1alpha, and TRAF1 in primary bovine monocyte-derived macrophages |
| Q37315484 | Rheumatoid arthritis: a view of the current genetic landscape |
| Q33811753 | Signaling by tumor necrosis factor receptors: pathways, paradigms and targets for therapeutic modulation |
| Q36404247 | Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes |
| Q30578474 | TNF receptor associated factors in cytokine signaling. |
| Q58621104 | TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer |
| Q52661592 | TRAF molecules in inflammation and inflammatory diseases. |
| Q60949710 | TRAF1 Signaling in Human Health and Disease |
| Q36361121 | TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis |
| Q49169745 | TRAF1 is a TNF inducible regulator of NF-kappaB activation |
| Q38359234 | TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. |
| Q36291138 | TRAF1 is a key mediator for hepatic ischemia/reperfusion injury |
| Q74840082 | TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice |
| Q28138885 | TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis |
| Q79846143 | TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation |
| Q34649278 | TRAF1: lord without a RING. |
| Q73925277 | TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival |
| Q28587065 | TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs |
| Q34546023 | The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease. |
| Q28140478 | The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis |
| Q34369244 | Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall |
| Q35877201 | Tumor necrosis factor receptor-associated factor 1 (TRAF1) polymorphisms and susceptibility to autoimmune thyroid disease. |
| Q39872674 | Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation |
| Q40902300 | Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2. |
Search more.